Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000093751-26-000023·Beam Therapeutics Inc.
Schedule 13G ownership disclosure
Beam Therapeutics Inc
COMMON STOCK · CUSIP: 07373V105
Event date: 2025-12-31
- Filing-level shares
- 5,228,529.00
- Percent of class
- 5.2%
- STATE STREET CORPORATION
Shares: 5,228,529.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-26-000023
- Form type
- SCHEDULE 13G
- Filer
- Beam Therapeutics Inc.
- CIK
- CIK 1745999
- Filed
- Feb 09, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership